Detalles de la búsqueda
1.
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood
; 142(10): 865-877, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37300386
2.
CD33-directed immunotherapy with third-generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cells.
Int J Cancer
; 150(7): 1141-1155, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34766343
3.
Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells.
Cytotherapy
; 24(3): 311-319, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34711501
4.
Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients.
Int J Cancer
; 148(2): 419-428, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32683672
5.
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data.
Ann Hematol
; 100(8): 2087-2093, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33270162
6.
B-cell maturation antigen-specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives.
Int J Cancer
; 147(8): 2029-2041, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32270481
7.
Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(9): 1575-1580, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32422254
8.
Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients.
Int J Cancer
; 145(5): 1312-1324, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30737788
9.
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells.
Cancer Immunol Immunother
; 68(7): 1195-1209, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31177329
10.
Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells.
Cytotherapy
; 21(5): 566-578, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30910382
11.
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies.
Int J Mol Sci
; 20(10)2019 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31109083
12.
Chimeric antigen receptor transduced T cells: Tuning up for the next generation.
Int J Cancer
; 142(9): 1738-1747, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29119551
13.
Extracorporeal photopheresis as a promising strategy for the treatment of GvHD after CAR-T cell therapy.
Blood Adv
; 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38359409
14.
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
J Hematol Oncol
; 16(1): 79, 2023 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481608
15.
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy.
Nat Med
; 29(4): 906-916, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36914893
16.
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma.
Biomedicines
; 10(2)2022 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35203582
17.
Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation.
Vaccines (Basel)
; 10(2)2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35214787
18.
Comparison of single copy genebased duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19directed CAR T cells in treated patients.
Int J Oncol
; 60(5)2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35294040
19.
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.
BMJ Open
; 12(11): e066128, 2022 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368749
20.
The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy.
Front Immunol
; 12: 670286, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34135898